Study Suggests RNA-Protein Interactions as Coronavirus Drug Targets

Research published in Nature Communications indicates that targeting conserved viral RNA-protein interactions could offer new drug targets for coronaviruses, including SARS-CoV-2. This early proof of concept suggests a strategy to attack critical, less mutable points in the virus's life cycle, potentially leading to treatments effective against multiple coronaviruses and reducing drug resistance.